ASCO/ESMO Update on Locally Advanced HNSCC: Does the anti-PD1 Pembro Concomitant With RT Improve Carcinologic Outcomes vs. SOC Cetuximab-RT?

0 views
January 30, 2021
Comments 0
Login to view comments. Click here to Login